- Home
- Publications
- Publication Search
- Publication Details
Title
Current Evidence of the Role of the Myokine Irisin in Cancer
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 11, Pages 2628
Publisher
MDPI AG
Online
2021-05-27
DOI
10.3390/cancers13112628
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progress and challenges in the biology of FNDC5 and irisin
- (2021) Steffen Maak et al. ENDOCRINE REVIEWS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Serum Levels of Irisin and Omentin-1 in Breast Neoplasms and Their Association with Tumor Histology
- (2021) Grigorios Panagiotou et al. International Journal of Endocrinology
- The Effects of MiR-214-3p and Irisin/FNDC5 on the Biological Behavior of Osteosarcoma Cells
- (2020) Gong Cheng et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma
- (2020) Jia Zhang et al. DISEASE MARKERS
- Physical activity before, during and after chemotherapy for high-risk breast cancer: relationships with survival
- (2020) Rikki A Cannioto et al. JNCI-Journal of the National Cancer Institute
- Review of Research on the Role of Irisin in Tumors
- (2020) Deguo Zhang et al. OncoTargets and Therapy
- Irisin: Still chasing shadows
- (2020) Elke Albrecht et al. Molecular Metabolism
- FNDC5 promotes paclitaxel sensitivity of non-small cell lung cancers via inhibiting MDR1
- (2020) Guo-Hua Fan et al. CELLULAR SIGNALLING
- Irisin, an exercise myokine, potently suppresses tumor proliferation, invasion, and growth in glioma
- (2020) Chiun‐Wei Huang et al. FASEB JOURNAL
- Original Article Submitted to Molecular Therapy Oncolytics Irisin is a positive regulator for ferroptosis in pancreatic cancer
- (2020) Bao Chen Yang et al. Molecular Therapy-Oncolytics
- Integrin-Ligand Interactions in Inflammation, Cancer, and Metabolic Disease: Insights Into the Multifaceted Roles of an Emerging Ligand Irisin
- (2020) Eun Jeong Park et al. Frontiers in Cell and Developmental Biology
- Serum irisin levels are decreased in patients with sepsis, and exogenous irisin suppresses ferroptosis in the liver of septic mice
- (2020) Shasha Wei et al. Clinical and Translational Medicine
- Physical Activity and Breast Cancer Prevention: Possible Role of Immune Mediators
- (2020) Yitong Xu et al. Frontiers in Nutrition
- The “irisin system”: From biological roles to pharmacological and nutraceutical perspectives
- (2020) Lorenzo Flori et al. LIFE SCIENCES
- Comparison of irisin hormone expression between thyroid cancer tissues and oncocytic variant cells
- (2019) Kader Ugur et al. Cancer Management and Research
- Immunostaining characteristics of irisin in benign and malignant renal cancers
- (2019) T. Kuloğlu et al. BIOTECHNIC & HISTOCHEMISTRY
- Icariin induces irisin/FNDC5 expression in C2C12 cells via the AMPK pathway
- (2019) Sui-Qing Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Irisin as a Multifunctional Protein: Implications for Health and Certain Diseases
- (2019) Paulina Korta et al. Medicina-Lithuania
- Irisin functions to inhibit malignant growth of human pancreatic cancer cells via downregulation of the PI3K/AKT signaling pathway
- (2019) Deguo Zhang et al. OncoTargets and Therapy
- Irisin Enhances Doxorubicin-Induced Cell Apoptosis in Pancreatic Cancer by Inhibiting the PI3K/AKT/NF-κB Pathway
- (2019) Jiayu Liu et al. MEDICAL SCIENCE MONITOR
- The diagnostic and prognostic roles of serum irisin in bladder cancer
- (2019) Marwa M. Esawy et al. CURRENT PROBLEMS IN CANCER
- Irisin reverses intestinal epithelial barrier dysfunction during intestinal injury via binding to the integrin αVβ5 receptor
- (2019) Jianbin Bi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Expression of Irisin/FNDC5 in Cancer Cells and Stromal Fibroblasts of Non-small Cell Lung Cancer
- (2019) Nowinska et al. Cancers
- The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives
- (2019) Gerasimos Socrates Christodoulatos et al. Current Obesity Reports
- Pathophysiological role of endogenous irisin against tumorigenesis and metastasis: Is it a potential biomarker and therapeutic?
- (2019) Dewan Md. Sumsuzzman et al. TUMOR BIOLOGY
- Serum irisin associates with breast cancer to spinal metastasis
- (2018) Zheng-ping Zhang et al. MEDICINE
- The diagnostic value of FNDC5/Irisin in renal Cell Cancer
- (2018) Diler Us Altay et al. International Braz J Urol
- Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway
- (2018) Jiayu Liu et al. Scientific Reports
- Serum and Adipose Tissue mRNA Levels of ATF3 and FNDC5/Irisin in Colorectal Cancer Patients With or Without Obesity
- (2018) Huijuan Zhu et al. Frontiers in Physiology
- Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors
- (2018) Hyeonwoo Kim et al. CELL
- mTOR as a central hub of nutrient signalling and cell growth
- (2018) Joungmok Kim et al. NATURE CELL BIOLOGY
- Epidemiology and biology of physical activity and cancer recurrence
- (2017) Christine M. Friedenreich et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway
- (2017) Gang Kong et al. ONCOLOGY REPORTS
- Increased FNDC5/Irisin expression in human hepatocellular carcinoma
- (2017) Melania Gaggini et al. PEPTIDES
- Lack of Adipocyte-Fndc5/Irisin Expression and Secretion Reduces Thermogenesis and Enhances Adipogenesis
- (2017) D. Pérez-Sotelo et al. Scientific Reports
- Irisin immunohistochemistry in gastrointestinal system cancers
- (2016) S Aydin et al. BIOTECHNIC & HISTOCHEMISTRY
- Exercise-induced biochemical changes and their potential influence on cancer: a scientific review
- (2016) Robert James Thomas et al. BRITISH JOURNAL OF SPORTS MEDICINE
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- RAS isoforms and mutations in cancer at a glance
- (2016) G. Aaron Hobbs et al. JOURNAL OF CELL SCIENCE
- Investigation of the expression of irisin and some cachectic factors in mice with experimentally induced gastric cancer
- (2016) Diler Us Altay et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults
- (2016) Steven C. Moore et al. JAMA Internal Medicine
- Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics
- (2015) Xeni Provatopoulou et al. BMC CANCER
- Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry
- (2015) Mark P. Jedrychowski et al. Cell Metabolism
- Study on the Distribution and Elimination of the New Hormone Irisin In Vivo: New Discoveries Regarding Irisin
- (2015) J. Lv et al. HORMONE AND METABOLIC RESEARCH
- Irisin – a myth rather than an exercise-inducible myokine
- (2015) Elke Albrecht et al. Scientific Reports
- Irisin and Myonectin Regulation in the Insulin Resistant Muscle: Implications to Adipose Tissue: Muscle Crosstalk
- (2015) Luis Gamas et al. Journal of Diabetes Research
- Circulating Irisin Levels Are Positively Associated with Metabolic Risk Factors in Sedentary Subjects
- (2015) María Moreno et al. PLoS One
- PI3K/AKT signaling pathway and cancer: an updated review
- (2014) Miriam Martini et al. ANNALS OF MEDICINE
- Recent Recreational Physical Activity and Breast Cancer Risk in Postmenopausal Women in the E3N Cohort
- (2014) A. Fournier et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Significantly greater reduction in breast cancer mortality from post-diagnosis running than walking
- (2014) Paul T. Williams INTERNATIONAL JOURNAL OF CANCER
- Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behaviorin vitro
- (2014) Nicholas P. Gannon et al. INTERNATIONAL JOURNAL OF CANCER
- A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues
- (2014) Suleyman Aydin et al. PEPTIDES
- Physical Activity and its Relation to Cancer Risk: Updating the Evidence
- (2013) Joanna Kruk et al. Asian Pacific Journal of Cancer Prevention
- Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling
- (2013) Y. Zhang et al. DIABETES
- Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle
- (2013) Tizhong Shan et al. FASEB JOURNAL
- Adipo-Myokines: Two Sides of the Same Coin—Mediators of Inflammation and Mediators of Exercise
- (2013) Silja Raschke et al. MEDIATORS OF INFLAMMATION
- Regulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines
- (2013) Hyun-Seuk Moon et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Evidence against a Beneficial Effect of Irisin in Humans
- (2013) Silja Raschke et al. PLoS One
- Targeting the PI3K-AKT-mTOR signaling network in cancer
- (2013) Khurum H. Khan et al. Chinese Journal of Cancer
- Role of PGC-1α signaling in skeletal muscle health and disease
- (2012) Chounghun Kang et al. Annals of the New York Academy of Sciences
- Updates of mTOR Inhibitors
- (2012) Hongyu Zhou et al. Anti-Cancer Agents in Medicinal Chemistry
- Irisin, Turning Up the Heat
- (2012) Francesc Villarroya Cell Metabolism
- The mTOR Signalling Pathway in Human Cancer
- (2012) Helena Pópulo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
- (2012) Pontus Boström et al. NATURE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Does Physical Activity Reduce the Risk of Prostate Cancer? A Systematic Review and Meta-analysis
- (2011) YuPeng Liu et al. EUROPEAN UROLOGY
- Activated PI3K/Akt/COX-2 Pathway Induces Resistance to Radiation in Human Cervical Cancer HeLa Cells
- (2010) Shu Xia et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- State of the epidemiological evidence on physical activity and cancer prevention
- (2010) Christine M. Friedenreich et al. EUROPEAN JOURNAL OF CANCER
- The PI3-K/AKT-Pathway and Radiation Resistance Mechanisms in Non-small Cell Lung Cancer
- (2009) Olga C.J. Schuurbiers et al. Journal of Thoracic Oncology
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started